HER2 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
HER2 tests Market Report Overview
The HER2 tests market size was valued at $123.6 million in 2023. The HER2 tests market will grow at a CAGR of more than 1% from 2023 to 2033. HER2 Testing includes extracting a sample of tumor tissue in a procedure called biopsy, which may be either fine-needle aspiration biopsy, core needle or surgical biopsy. HER2 status can also be determined by next-generation sequencing and array comparative genomic hybridization (aCGH).
HER2 tests Market Outlook 2023-2033 ($ Million)
Buy the Full Report for More Insights on the HER2 tests Market Forecast, Download a Free Sample Report
The HER2 tests market research report explains the market behavior, which will help identify quantitative market trends within diagnostic imaging therapeutic areas. The report has extensively covered regional-wise quantitative data, highlighting the number of HER2 tests across labs, which will help in identifying untapped market opportunities. The HER2 tests market model also discusses the detailed impact of COVID-19 on the HER2 tests market for 2020 and beyond.
Market Size (2023) | $123.6 million |
CAGR (2023-2033) | >1% |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
HER2 Tests Market Dynamics
The market for HER2 amplification tests will grow across all regions during the forecast period (post-pandemic period). This growth is owing to factors such as rising breast and gastric cancer incidence, greater disease awareness, improved accessibility to companion diagnostics in emerging economies, and technological advancements. The use of IHC and ISH will remain a staple in determining HER2 status. However, NGS is gaining popularity, especially in Europe.
Buy the Full Report for Additional HER2 Tests Market Dynamics, Download a Free Sample Report
HER2 Tests Market Segments
The key segments in the HER2 tests market are HER2 Comparative Genomic Hybridization (aCGH) Tests, HER2 Immunohistochemistry Tests, and HER2 In Situ Hybridisation Tests. In 2023, the HER2 Immunohistochemistry Tests segment led the HER2 tests market share. Immunohistochemistry (IHC) is a well-established and widely used method in routine biopsy tissue diagnosis. The technique is used to detect cell surface and intracellular proteins in fixed tissues using antibodies.
HER2 tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment-Wise Insights in the HER2 Tests Market, Download a Free Sample Report
HER2 Tests Market Segmentation by Regions
The key regions in the HER2 tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, Europe emerged as the HER2 tests market leader.
HER2 testing rates for breast and gastric cancer will increase in Europe, during the forecast period. The European Society for Medical Oncology (ESMO), including 26 European countries, recommends HER2 gene amplification status should be determined directly from all invasive tumors for breast cancer. For gastric cancer, HER2 testing is recommended for patients with advanced, metastatic, gastric adenocarcinoma, who may benefit from targeted therapy.
HER2 tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights in the HER2 Tests Market, Download A Free Sample Report
HER2 Tests Market – Competitive Landscape
The key companies in the HER2 tests market are Foundation Medicine Inc, Agilent Technologies Inc, Abbott Laboratories, Leica Biosystems Nussloch GmbH, and MilliporeSigma + Sigma Aldrich among others. In 2023, Foundation Medicine Inc accounted for the highest HER2 tests market share and value.
HER2 Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the HER2 Tests Market, Download a Free Sample Report
Segments Covered in this Report.
HER2 Tests Segment Outlook ($ Million, 2015-2033)
- HER2 Comparative Genomic Hybridization (aCGH) Tests
- HER2 Immunohistochemistry Tests
- HER2 In Situ Hybridisation Tests
HER2 Tests Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
Currently marketed HER2 tests market and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total HER2 tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the HER2 tests market.
- Competitive dynamics insights and trends provided for the HER2 tests market.
Get a thorough understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Agilent Technologies Inc, Amoy Diagnostics Co Ltd, Biocare Medical LLC, Merck KGaA,F. Hoffmann-La Roche Ltd, Illumina Inc, Danaher Corp, medac GmbH, New England Biolabs Inc, Qiagen NV, Sysmex Corp, Thermo Fisher Scientific Inc, and Others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for
- CMO executives who must have a deep understanding of the HER2 tests marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Understand the impact of COVID-19 on HER2 tests.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving HER2 tests.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the HER2 tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific HER2 tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Agilent Technologies Inc
Amoy Diagnostics Co Ltd
Biocare Medical LLC
Merck KGaA
F. Hoffmann-La Roche Ltd
Illumina Inc
Danaher Corp
medac GmbH
New England Biolabs Inc
Qiagen NV
Sysmex Corp
Thermo Fisher Scientific Inc
Others
Frequently asked questions
-
What was the HER2 tests market size in 2023?
The HER2 tests market size was $123.6 million in 2023.
-
What will the CAGR of the HER2 tests market be during 2023-2033?
The HER2 tests will grow at a CAGR of more than 1% during 2023-2033.
-
Which was the leading segment in the HER2 tests market in 2023?
Real-Time 3D/4D HER2 tests segment was leading the HER2 tests market in 2023.
-
Which region held the largest share of the HER2 tests market in 2023?
Asia-Pacific was the largest regional market for HER2 tests in 2023.
-
Which are the leading players in the HER2 tests market?
The key companies in the HER2 tests market are GE Healthcare Technologies Inc, Siemens Healthineers AG, Philips Healthcare, Canon Medical Systems Corp, Hitachi Healthcare Manufacturing Ltd, Samsung Medison Co Ltd, Fujifilm Holdings Corp, Esaote SpA and Others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.